Nanotechnology and CSC Targeting

Nanotechnology offers a promising approach for selectively targeting cancer stem cells (CSCs) with greater precision. This track focuses on the development of nanoparticle-based drug delivery systems that can specifically target CSCs while minimizing damage to normal cells. Researchers explore how nanoparticles can be engineered to deliver therapeutic agents directly to CSCs by recognizing specific surface markers or responding to the unique microenvironment of CSCs. Nanotechnology also enables the delivery of combination therapies, such as chemotherapy and immunotherapy, to effectively eliminate CSCs and prevent tumor recurrence. This research holds the potential to revolutionize cancer treatment by improving the specificity and efficacy of CSC-targeted therapies.

    Related Conference of Nanotechnology and CSC Targeting

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Nanotechnology and CSC Targeting Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in